STELIOS PAPADOPOULOS

Insider Reports History

Location
Alameda, CA
Signature
/s/ Nina Ayer, Attorney in Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by STELIOS PAPADOPOULOS:

Company Role Class Num Shares Value Price $ Report Date Ownership
EXELIXIS, INC. Director Common Stock 1,189,228 $51,790,879 $43.55 12 Nov 2025 Direct
BIOGEN INC. Director Common Stock 17,375 $4,309,000 $248.00 15 Jun 2022 Stelios Holdings, LLC
BIOGEN INC. Director Common Stock 10,831 $2,686,088 $248.00 15 Jun 2022 Esperanza Holdings, LLC
BIOGEN INC. Director Common Stock 10,095 $2,503,560 $248.00 15 Jun 2022 Direct
Ovid Therapeutics Inc. Director Common Stock 200,000 $112,000 $0.5600 01 Mar 2025 Direct
Regulus Therapeutics Inc. Director Common Stock 0 $0 $7.93 25 Jun 2025 Direct
Ovid Therapeutics Inc. Director Stock Option (right to buy) 90,000 03 Mar 2025 Direct
EXELIXIS, INC. Director Option (right to buy) 0 15 May 2025 Direct
Regulus Therapeutics Inc. Director Common Stock Purchase Warrant (Right to Buy) 0 25 Jun 2025 Direct
Regulus Therapeutics Inc. Director Stock Option 0 25 Jun 2025 Direct

Insider Reports Filed by STELIOS PAPADOPOULOS

Symbol Company Period Transactions Value $ Form Type Role Filing Time
EXEL EXELIXIS, INC. 12 Nov 2025 1 -$4,355,000 4 Director 13 Nov 2025, 19:12
RGLS Regulus Therapeutics Inc. 25 Jun 2025 11 $0 4 Director 27 Jun 2025, 17:11
EXEL EXELIXIS, INC. 29 May 2025 1 $0 4 Director 30 May 2025, 19:13
EXEL EXELIXIS, INC. 15 May 2025 6 -$885,779 4 Director 16 May 2025, 20:57
RGLS Regulus Therapeutics Inc. 30 Apr 2025 1 $0 4 Director 30 Apr 2025, 16:30
OVID Ovid Therapeutics Inc. 03 Mar 2025 1 $0 4 Director 04 Mar 2025, 16:44
OVID Ovid Therapeutics Inc. 01 Mar 2025 0 $0 3 Director 04 Mar 2025, 16:42
EXEL EXELIXIS, INC. 31 May 2024 1 $0 4 Director 04 Jun 2024, 20:21
EXEL EXELIXIS, INC. 20 May 2024 3 -$11,482 4 Director 22 May 2024, 19:23
RGLS Regulus Therapeutics Inc. 20 May 2024 1 $0 4 Director 21 May 2024, 16:23
RGLS Regulus Therapeutics Inc. 16 May 2024 1 $0 4 Director 17 May 2024, 16:38
RGLS Regulus Therapeutics Inc. 14 Mar 2024 1 +$400,000 4 Director 15 Mar 2024, 16:19
RGLS Regulus Therapeutics Inc. 10 Aug 2023 1 $0 4 Director 14 Aug 2023, 16:28
RGLS Regulus Therapeutics Inc. 13 Jun 2023 1 $0 4 Director 13 Jun 2023, 16:50
EXEL EXELIXIS, INC. 01 Jun 2023 1 $0 4 Director 02 Jun 2023, 21:13
RGLS Regulus Therapeutics Inc. 13 Apr 2023 1 +$200,000 4 Director 14 Apr 2023, 16:39
BIIB BIOGEN INC. 15 Jun 2022 1 $0 4 Director 17 Jun 2022, 17:13
RGLS Regulus Therapeutics Inc. 09 Jun 2022 1 $0 4 Director 10 Jun 2022, 16:18
EXEL EXELIXIS, INC. 26 May 2022 1 $0 4 Director 27 May 2022, 21:19
EXEL EXELIXIS, INC. 22 Feb 2022 1 -$1,653,113 4 Director 24 Feb 2022, 19:22
RGLS Regulus Therapeutics Inc. 30 Nov 2021 1 +$800,000 4 Director 01 Dec 2021, 15:12
BIIB BIOGEN INC. 01 Jul 2021 1 $0 4 Director 02 Jul 2021, 17:27
RGLS Regulus Therapeutics Inc. 14 Jun 2021 1 $0 4 Director 15 Jun 2021, 16:43
EXEL EXELIXIS, INC. 27 May 2021 1 $0 4 Director 28 May 2021, 20:26
EXEL EXELIXIS, INC. 11 May 2021 9 -$6,394 4 Director 13 May 2021, 20:32